Form 4: Sotera Health Director Robert Knauss Receives Restricted Stock Unit Grant

Sotera Health Co. director Robert Knauss was granted 19,132 restricted stock units as part of his compensation, aligning his interests with shareholders.

Summary

• Robert Knauss, a Director of Sotera Health Co. (SHC), was granted 19,132 restricted stock units (RSUs) on May 22, 2025.
• These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock.
• The RSUs will vest in full on the earlier of May 22, 2026 (first anniversary of grant date) or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on Mr. Knauss's continued service as a non-employee director.
• Following this transaction, Mr. Knauss beneficially owns a total of 54,933 securities, comprising 19,132 RSUs and 35,801 shares of Common Stock.

Sentiment

Score: 6

Explanation: The grant of Restricted Stock Units (RSUs) to a director is a standard compensation practice that aligns the director's interests with shareholders. While it involves minor potential future dilution, it is generally viewed as a neutral to slightly positive event, reflecting ongoing corporate governance and compensation practices.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Robert Knauss aligns his interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
• The transaction is part of a pre-existing and approved incentive plan (Sotera Health Company 2020 Omnibus Incentive Plan), indicating a structured approach to executive and director compensation.

Negatives

• The issuance of new RSUs, upon vesting and conversion to common stock, will result in a minor dilution of existing shareholders' equity.

Future Outlook

The document indicates that the granted Restricted Stock Units (RSUs) are subject to vesting conditions, which will occur on the earlier of the first anniversary of the grant date (May 22, 2026) or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on the director's continued service.

Industry Context

The granting of restricted stock units to non-employee directors is a common practice across various industries, including healthcare and specialized services like those provided by Sotera Health. This compensation structure is widely used to attract and retain qualified board members and to align their financial interests with the long-term performance of the company, a standard corporate governance practice.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) to a non-employee director, such as Robert Knauss at Sotera Health Co., is a standard practice in corporate governance and executive compensation across publicly traded companies.
• Similar RSU grants are common at companies like Steris plc (STE) or Cantel Medical Corp. (CMD, now part of Steris), which operate in related healthcare sterilization and infection prevention markets.
• The specific number of units and vesting schedule are typically determined by the company's compensation committee based on market benchmarks for director compensation, company size, and performance, though this document does not provide specific comparative data.
• The use of an Omnibus Incentive Plan is also a standard mechanism for equity-based compensation.

Corporate Governance

Related Party Transactions

• The grant of 19,132 Restricted Stock Units (RSUs) to Robert Knauss, a director of Sotera Health Co., constitutes a transaction with a related party (an insider). This is a standard form of compensation for non-employee directors and is disclosed as required by SEC regulations.

Stakeholder Impact

• Shareholders: Minor potential future dilution upon vesting and conversion of RSUs to common stock, but also potential benefit from aligned director interests.
• Director (Robert Knauss): Receives equity-based compensation, tying his financial incentives to the company's stock performance.

Next Steps

• Vesting of the 19,132 Restricted Stock Units (RSUs) on the earlier of May 22, 2026, or the date immediately prior to Sotera Health Co.'s next regular annual shareholders meeting, subject to continued service.

Key Dates

Keywords

Sotera Health Co., SHC, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant, Stock Incentive Plan